Chemical Compound

Ceftobiprole medocaril

CAS Registry Number 376653-43-9
Ceftobiprole medocaril chemical structure
Primary Record

Ceftobiprole medocaril

Note: Only for scientific research or as raw materials for production.

In stock
7,642 g
Purity
98.1 %
CAS
376653-43-9

Compound Identifiers & Properties

CAS
376653-43-9
PubChem CID
135413544
SMILES
CC1=C(OC(=O)O1)COC(=O)N2CC[C@H](C2)N3CC/C(=C\C4=C(N5[C@@H]([C@@H](C5=O)NC(=O)/C(=N\O)/C6=NSC(=N6)N)SC4)C(=O)O)/C3=O
Canonical SMILES
Cc1oc(=O)oc1COC(=O)N1CC[C@@H](N2CC/C(=C\C3=C(C(=O)O)N4C(=O)[C@@H](NC(=O)/C(=N\O)c5nsc(N)n5)[C@H]4SC3)C2=O)C1

Names & Synonyms

  • Ceftobiprole medocaril
  • Ceftobiprole medocaril sodium
  • ceftobiprolemedocaril
  • UNII-YXV28V1B07
  • ceftobiprole medocaril free acid
  • 376653-43-9
  • RefChem:918194
  • Ceftobiprole Medocaril [INN]
  • BAL5788
  • YXV28V1B07
  • orb1303246
  • SCHEMBL2671859
  • BAL9141
  • Ceftobiprole medocaril sodium salt
  • CHEBI:135968
  • HFTSMHTWUFCYMJ-FDNJTQOMSA-N
  • DTXCID801506580
  • DTXSID601021562
  • CEFTOBIPROLE MEDOCARIL [MI]
  • BAL 5788
  • BAL 9141
  • BAL-5788
  • BAL-9141
  • Ro 65-5788
  • AKOS040758097
  • AT43358
  • CEFTOBIPROLE MEDOCARIL [WHO-DD]
  • DB14733
  • N99027V28J
  • Ro-655788
  • BAL5788-001
  • JNJ30982081
  • Ro-65-5788
  • BAL 9141-000
  • BAL-5788-001
  • DA-62194
  • FC168067
  • TS-08967
  • HY-106574
  • CS-0026087
  • 1-Ethyl-3-methylimidazolium bis(dioxalate)-borate
  • 653C439
  • Q27294766
  • 252188-71-9
  • B2692-292584
  • (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-hydroxyiminoacetyl]amino]-3-[(E)-[1-[(3R)-1-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxycarbonyl]pyrrolidin-3-yl]-2-oxopyrrolidin-3-ylidene]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • (6R,7R)-7-(((2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-hydroxyiminoacetyl)amino)-3-((E)-(1-((3R)-1-((5-methyl-2-oxo-1,3-dioxol-4-yl)methoxycarbonyl)pyrrolidin-3-yl)-2-oxopyrrolidin-3-ylidene)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
  • (6R,7R)-7-((2Z)-2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-(hydroxyimino)acetamido)-3-((E)((3'R)-1'-((5-methyl-2-oxo-1,3-dioxol-4-yl)methoxycarbonyl)-2-oxo-(1,3'-bipyrrolidin)-3-ylidene)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
  • (6R,7R)-7-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2(Z)-(hydroxyimino)acetamido]-3-[(E)-1-[1-(5-methyl-2-oxo-1,3-dioxol-4-ylmethoxycarbonyl)pyrrolidin-3(R)-yl]-2-oxopyrrolidin-3-ylidenemethyl]-3-cephem-4-carboxylic acid
  • 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2Z)-(5-amino-1,2,4-thiadiazol-3-yl) (hydroxyimino)acetyl)amino)-3-((E)-((3'R)-1'-(((5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy)carbonyl)-2-oxo(1,3'-bipyrrolidin)-3-ylidene)methyl)-8-oxo-, monosodium salt, (6R,7R)-
  • Ceftobiprole Medocaril; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(hydroxyimino)acetyl]amino]-3-[(E)-[(3'R)-1'-[[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl]-2-oxo[1,3'-bipyrrolidin]-3-ylidene]methyl]-8-oxo-, (6R,7R)